Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Breast Neoplasms 29Colonic Neoplasms 13Colorectal Neoplasms 12Rectal Neoplasms 10Prostatic Neoplasms 9Neoplasms 8Endometrial Neoplasms 7Uterine Cervical Neoplasms 6Lung Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Overweight 5Obesity 5Motor Activity 5Anxiety Disorders 5Sexuality 4Sexual Dysfunction, Physiological 4Ovarian Neoplasms 4Depression 4Breast Carcinoma In Situ 4Unspecified Adult Solid Tumor, Protocol Specific 3Small Cell Lung Carcinoma 3Pancreatic Neoplasms 3Carcinoma, Ovarian Epithelial 3Carcinoma, Intraductal, Noninfiltrating 3Behavior 3Vulvar Neoplasms 2Vaginal Neoplasms 2Urinary Bladder Neoplasms 2Tobacco Use Disorder 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2

Interventions

Salpingo-oophorectomy 2Genetic Testing 2Genetic Counseling 2Diet, Mediterranean 2Videotape Recording 1Telemedicine 1Standard of Care 1Specimen Handling 1Salpingectomy 1Practice Guidelines as Topic 1Ovariectomy 1Methods 1Genotype 1Counseling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Hereditary Breast and Ovarian Cancer Syndrome × Counseling × Clear all
NCT06534424 2025-06-27

Clinical Impact of Enhanced Risk Assessments in Women With a BRCA1/2 Mutation, CARE Study

Ohio State University Comprehensive Cancer Center

Phase NA Completed
152 enrolled
BreastGynecologic

Hereditary Breast and Ovarian Cancer Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡